| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2006 | US20060003977 Tibolone-adsorbates |
| 01/05/2006 | US20060003976 Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003974 Bile acid derived steroidal dimers with amphiphilic topology having antiproliferative activity |
| 01/05/2006 | US20060003973 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 01/05/2006 | US20060003972 Inflammatory bowel disease (IBD) and irritable bowel syndrome, Crohn's disease, ulcerative colitis |
| 01/05/2006 | US20060003971 such as A-ring aromatized Minocycline, having antibacterial activity; antibiotics |
| 01/05/2006 | US20060003970 Novel combi-molecules having EGFR and DNA targeting properties |
| 01/05/2006 | US20060003969 Compositions and methods for treating pathological infections |
| 01/05/2006 | US20060003968 allergies, proliferative diseases, autoimmune diseases, bone disorders; pyrrolo[2,3-b]pyridine derivatives |
| 01/05/2006 | US20060003967 Method for preparing pyrrolotriazine compounds |
| 01/05/2006 | US20060003966 Carbazole formulations for the treatment of psoriasis and angiogenesis |
| 01/05/2006 | US20060003965 N-acetyl-d-glucosamine (nag) supplemented food products and beverages |
| 01/05/2006 | US20060003964 Hyaluronate-based viscoelastic agent and low viscosity, chondroitin sulfate and hydroxypropylmethylcellulose-containing solution; for use in intr-articular therapy and as vitreous replacement in vitreo-retinal surgery |
| 01/05/2006 | US20060003963 Oxidizing and fluorinating the anhydroglucose to obtain 2-deoxy-2,2-difluoro-D-ribofuranose as intermediate; can be used in large-scale production |
| 01/05/2006 | US20060003962 Methods and products related to treatment and prevention of hepatitis C virus infection |
| 01/05/2006 | US20060003960 Tumor treatment |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003951 Anti-viral 7-deaza L-nucleosides |
| 01/05/2006 | US20060003950 Method of treating prostatic diseases using a combination of vitamin D analogues and other agents |
| 01/05/2006 | US20060003949 Freeze-dried preparation of stabilized anthracycline compound |
| 01/05/2006 | US20060003948 Compositions that include a triterpene and a carrier |
| 01/05/2006 | US20060003947 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
| 01/05/2006 | US20060003946 Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity |
| 01/05/2006 | US20060003945 serotonin 5-HT6 receptor moodulators for the treatment of central nervous system like anxiety, depression, epilepsy, ADHD; N-(2-{1-[(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]-1H-indol-3-yl}ethyl)acetamide; method to determine the metabolism of an indolylalkylamine derivative |
| 01/05/2006 | US20060003942 Combinations for HCV treatment |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003933 Compositions and methods for treatment of neovascular diseases |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003927 Modulation of immune function |
| 01/05/2006 | US20060003925 Using adenosine monophosphate moderator and phosphodiesterase inhibitor |
| 01/05/2006 | US20060003923 Stability, reduced toxicity; covalently linked imidazole functionality |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003918 Prolonged delivery of peptides |
| 01/05/2006 | US20060003915 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/05/2006 | US20060003431 Structure of protein kinase C theta |
| 01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/05/2006 | US20060003346 Method for treating hepatitis |
| 01/05/2006 | US20060003326 Bioconjugation; spiegelmers, aptamers |
| 01/05/2006 | US20060003083 Food containing glycine and use thereof |
| 01/05/2006 | US20060003034 Skin cleanser for treating acne vulgaris, acne rosacea and seborrheic dermatitis containing sulfur, sodium sulfacetamide and low HLB emulsifiers including glycerin, methyl paraben, propyl paraben, allantoin, sodium methyl oleyltaurate, disodium oleamido MEA sulfosuccinate, sodium cocoyl isethionate |
| 01/05/2006 | US20060003033 includes a pharmaceutically effective amount of estradiol, estriol, hyaluronic acid, and green tea extract for topical administration to the skin; may also be useful for improving urogenital function |
| 01/05/2006 | US20060003027 Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 01/05/2006 | US20060003026 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
| 01/05/2006 | US20060003023 Microbicidal composition |
| 01/05/2006 | US20060003021 Method of treating breast cancer using a combination of vitamin d analogues and other agents |
| 01/05/2006 | US20060003020 Anti-metastatic ability of mibefradil and gadolinium |
| 01/05/2006 | US20060003012 Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| 01/05/2006 | US20060003011 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 01/05/2006 | US20060003005 Tablet for pulsed delivery |
| 01/05/2006 | US20060003002 Pharmaceutical compositions with synchronized solubilizer release |
| 01/05/2006 | US20060003001 Chronotherapeutic compositions and methods of their use |
| 01/05/2006 | US20060002999 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 01/05/2006 | US20060002998 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations |
| 01/05/2006 | US20060002997 Nitrofurantoin controlled release dosage form |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002989 Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| 01/05/2006 | US20060002985 Compositions and methods for decreasing age-related deterioration in mental activities in companion animals |
| 01/05/2006 | US20060002983 Muscle building preparation |
| 01/05/2006 | US20060002982 Xanthan gum viscoelastic composition, method of use and package |
| 01/05/2006 | US20060002981 Filling a lens capsule bag of mammal with hyaluronic acid solution formulated to biodegrade or dissolve at least 2 weeks later; collagen product may be injected to improve cell proliferation and differentiation, and to improve configuration and shape; optics, vision defects; tissue engineering |
| 01/05/2006 | US20060002980 High density fibrous polymers suitable for implant |
| 01/05/2006 | US20060002977 Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
| 01/05/2006 | US20060002974 Polycationic peptide coatings and methods of coating implantable medical devices |
| 01/05/2006 | US20060002972 Reconstruction of urological structures with polymeric matrices |
| 01/05/2006 | US20060002968 Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
| 01/05/2006 | US20060002967 Resorbable implant with lubricious coating |
| 01/05/2006 | US20060002966 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/05/2006 | US20060002963 Use of emulsions for intra and periocular injections |
| 01/05/2006 | US20060002938 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation |
| 01/05/2006 | US20060002937 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 01/05/2006 | US20060002934 Egf receptor antagonists in the treatment of gastric cancer |
| 01/05/2006 | US20060002930 Treatment of disorders |
| 01/05/2006 | US20060002919 15625 receptor, a novel G-protein coupled receptor |
| 01/05/2006 | US20060002918 Thrombin compositions |
| 01/05/2006 | US20060002914 treating or preventing axonal degradation in neuropathic diseases in mammals; axonopathy; administering an agent (such as NAD, NADH) that increases sirtuin activity in diseased and/or injured neurons and supporting cells in an amount effective to decrease axonal degeneration |
| 01/05/2006 | US20060002913 Use of histamine and related compounds to treat disorders affecting muscle function |
| 01/05/2006 | US20060002911 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 01/05/2006 | US20060002895 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 01/05/2006 | US20060002894 Method for introducing a biological molecule using a viral envelope and composition and system therefor |
| 01/05/2006 | US20060002890 Hydrogel formulations |
| 01/05/2006 | US20060002889 Polyionene polymers with hydrolyzable linkages |
| 01/05/2006 | US20060002888 Polyionenes for treating infections associated with cystic fibrosis |
| 01/05/2006 | US20060002887 Ionene oligomers and polymers |
| 01/05/2006 | US20060002881 Perfluorocarbon-soluble compounds |
| 01/05/2006 | US20060002874 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 01/05/2006 | US20060002866 Method for protecting the skin from aging |
| 01/05/2006 | US20060002864 Milling process for the production of finely milled medicinal substances |
| 01/05/2006 | US20060002863 Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant |
| 01/05/2006 | US20060002861 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 01/05/2006 | US20060002860 Abuse-proofed oral dosage form |
| 01/05/2006 | US20060002858 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | US20060000252 A particulate plant nutrient coated by the reactionproduct of a mixture comprising a diisocyanate and/or an epoxy resin, a sulfur-containing vegetable oil and a crosslinked thioacrylate ester; polythiourethanes; wear resistance; strength; encapsulation; water solubility; environmentally friendly |